Venous retention needle suite with hirudin anticoagulation tube sealing device
A technology of intravenous indwelling needles and hirudin, which is applied in the field of medical devices, can solve the problems of cumbersome extraction steps of natural hirudin, limitations in research and clinical application, and difficulty in obtaining a sufficient amount of pure products, so as to reduce the risk of phlebitis and reduce the risk of medical treatment. The effects of preventing disputes and reducing the workload of nurses
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] figure 1 It is a structural schematic diagram of the intravenous indwelling needle set with the hirudin anticoagulant blood sealing device of the present invention. Such as figure 1 As shown, the venous indwelling needle set with the hirudin anticoagulant blood sealing device of the present invention includes a sleeve 1 guided by a puncture needle 17 and inserted into the vein, and a transparent transparent plug 3 connected to the built-in isolation sealing plug 3 at the rear end of the sleeve 1. The tee 2 and the infusion connector 6 for connecting the infusion line or the blood collection line.
[0046] One end of the transparent tee 2 is connected to the casing 1 , one end is sealed by an isolation sealing plug 3 , and the third end is connected to the infusion joint 6 through the extension tube 4 . The cannula 1 is sleeved on the outside of the puncture needle 17 , and the tip of the puncture needle 17 protrudes from the front end of the cannula 1 . The rear end ...
Embodiment 2
[0053] comparative experiment
[0054] The concentration of hirudin is: 0.01mg / ml~50mg / ml, about 1ml-15ml for each use according to different needs.
[0055]
[0056]
[0057] The relationship between hirudin and coagulation factors is as follows:
[0058] First, recombinant hirudin and α-thrombin form a stable complex with equimolar non-covalent binding (the dissociation constant is very small, 0.8×10 -10 mol or 2.0×10 -14 mol). At this time, all protease hydrolysis functions of thrombin are blocked, so hirudin can not only prevent the coagulation of fibrinogen, but also block the hemostatic reaction catalyzed by thrombin, such as the activation of factors V, VIII and III and the thrombin-induced platelet The reaction prevents the generation of thrombin caused by the feedback of prothrombin activation. At the same time, hirudin does not interfere with the biosynthesis of coagulation factors, and has no effect on antithrombin III (AT-III).
[0059] Second, when hirud...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com